Source:http://linkedlifedata.com/resource/pubmed/id/16507843
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-3-1
|
pubmed:abstractText |
To investigate why human leukocyte-associated antigen-DRB1*0301 (HLA-DRB1*0301) positive Scandinavian patients have a better prognosis than HLA-DRB1*0301 negative patients, the present authors examined patterns of cytokine expression in bronchoalveolar lavage (BAL) cells and BAL fluid (BALF) from patients with pulmonary sarcoidosis and controls. Using real-time PCR, the mRNA expression of selected cytokines in BAL cells from newly diagnosed, untreated nonsmoking patients (n=25) and controls (n=11) was quantified. Cytokine protein levels in BALF from patients (n=34) and controls (n=11) were assessed using cytometric bead array. The patients were evaluated and stratified into two subgroups: HLA-DRB1*0301 positive (all with an acute onset) and HLA-DRB1*0301 negative (all with an insidious onset). When comparing patients and controls, BAL cells of the patients expressed significantly higher levels of interferon (IFN)-gamma and interleukin (IL)-10 mRNA. There were significantly decreased IFN-gamma and tumour necrosis factor (TNF)-alpha mRNA levels, and a tendency toward higher levels of transforming growth factor-beta1 mRNA in HLA-DRB1*0301 positive compared with HLA-DRB1*0301 negative patients. Protein levels of IL-1beta, IL-2, IL-6, IL-12p70 and TNF-alpha in BALF were significantly higher in patients. HLA-DRB1*0301 positive patients exhibited tendencies to lower levels of most cytokines in BALF. In conclusion, the present data show a reduced expression of T-helper cell type-1 cytokines in human leukocyte-associated antigen-DRB1*0301 positive patients, which may relate to their good prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
451-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16507843-Adult,
pubmed-meshheading:16507843-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:16507843-Female,
pubmed-meshheading:16507843-HLA-DR Antigens,
pubmed-meshheading:16507843-HLA-DRB1 Chains,
pubmed-meshheading:16507843-Humans,
pubmed-meshheading:16507843-Male,
pubmed-meshheading:16507843-Middle Aged,
pubmed-meshheading:16507843-Sarcoidosis, Pulmonary,
pubmed-meshheading:16507843-Th1 Cells
|
pubmed:year |
2006
|
pubmed:articleTitle |
Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis.
|
pubmed:affiliation |
Dept of Medicine, Division of Respiratory Medicine, Immune and Gene Therapy Laboratory, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden. Farah.Idali@medks.ki.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|